Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Federica, Giannotti"'
Autor:
Federica Giannotti, Carmen De Ramon Ortiz, Federico Simonetta, Sarah Morin, Chiara Bernardi, Stavroula Masouridi-Levrat, Yves Chalandon, Anne-Claire Mamez
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option for patients with highly chemorefractory Hodgkin lymphoma (HL). The CD30-targeting antibody-drug conjugate Brentuximab-Vedotin (BV) and programm
Externí odkaz:
https://doaj.org/article/cbfb749dbff44cd88f3e883f56499b63
Autor:
Sarah Morin, Federica Giannotti, Anne-Claire Mamez, Amandine Pradier, Stavroula Masouridi-Levrat, Federico Simonetta, Yves Chalandon
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Sorafenib significantly improves survival of FLT3-ITD mutated AML patients when used as a post-allogeneic HSCT maintenance. Importantly, clinical trials reported a low rate of toxicities requiring sorafenib discontinuation. The aim of our analysis wa
Externí odkaz:
https://doaj.org/article/4112719bae8044f9936b6400c0213214
Autor:
Micha Srour, Amandine Fayard, Federica Giannotti, Aurelien Giltat, Sarah Guenounou, Jean Roy, Justine Schmitt, Sophie Servais, Tamim Alsuliman, Ibrahim Yakoub Agha, Gaelle Guillerm
Publikováno v:
Bulletin du Cancer. 110:S67-S78
Autor:
Federica Giannotti, Myriam Labopin, Roni Shouval, Jaime Sanz, William Arcese, Emanuele Angelucci, Jorge Sierra, Josep-Maria Ribera Santasusana, Stella Santarone, Bruno Benedetto, Alessandro Rambaldi, Riccardo Saccardi, Didier Blaise, Michele Angelo Carella, Vanderson Rocha, Frederic Baron, Mohamad Mohty, Annalisa Ruggeri, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-10 (2018)
Abstract Background Thiotepa-busulfan-fludarabine (TBF) is a widely used conditioning regimen in single umbilical cord blood transplantation (SUCBT). More recently, it was introduced in the setting of non-T cell depleted haploidentical stem cell tran
Externí odkaz:
https://doaj.org/article/f82458ba826541f09f5cf80a3cdb3e17
Autor:
Nicole Santoro, Myriam Labopin, Federica Giannotti, Gerard Ehninger, Dietger Niederwieser, Arne Brecht, Matthias Stelljes, Nicolaus Kröger, Herman Einsele, Matthias Eder, Michael Hallek, Bertram Glass, Jürgen Finke, Fabio Ciceri, Mohamad Mohty, Annalisa Ruggeri, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-10 (2018)
Abstract Background Acute myeloid leukemia (AML) is both more common and with more biologically aggressive phenotype in the elderly. Allogenic stem cell transplantation (allo-SCT) is the best treatment option in fit patients. Either HLA-matched unrel
Externí odkaz:
https://doaj.org/article/1cf271159e1040f2bba1021b5de0b49c
Autor:
Emmanouil Glampedakis, Romain Roth, Stavroula Masouridi-Levrat, Yves Chalandon, Anne-Claire Mamez, Federica Giannotti, Christian Van Delden, Dionysios Neofytos
Publikováno v:
Journal of Fungi, Vol 7, Iss 10, p 811 (2021)
Background: Antifungal combination treatment is frequently administered for invasive mold infections (IMIs) after allogeneic hematopoietic cell transplantation (HCT). Here, we describe the indications, timing, and outcomes of combination antifungal t
Externí odkaz:
https://doaj.org/article/ff336ab8c913497aa8e2876cd5812198
Autor:
Romain Samuel Roth, Stavroula Masouridi‐Levrat, Federica Giannotti, Anne‐Claire Mamez, Sarah Morin, Christian van Delden, Yves Chalandon, Dionysios Neofytos
Publikováno v:
Mycoses. 65:1061-1067
Limited data exist to describe end-of-treatment (EOT) parameters of antifungal therapy for invasive mould infections (IMI).In a 10-year cohort of consecutive adult allogeneic haematopoietic cell transplant recipients with proven/probable IMI, we desc
Autor:
Giorgia Battipaglia, Florent Malard, Marie Therèse Rubio, Annalisa Ruggeri, Anne Claire Mamez, Eolia Brissot, Federica Giannotti, Remy Dulery, Anne Christine Joly, Minh Tam Baylatry, Marie Jeanne Kossmann, Jacques Tankovic, Laurent Beaugerie, Harry Sokol, Mohamad Mohty
Publikováno v:
Haematologica, Vol 104, Iss 8 (2019)
Fecal microbiota transplantation is an effective treatment in recurrent Clostridium difficile infection. Promising results to eradicate multidrug-resistant bacteria have also been reported with this procedure, but there are safety concerns in immunoc
Externí odkaz:
https://doaj.org/article/82a6dcf1e602408ebef09a7380d191ee
Autor:
Davide Bosetti, Chiara Bernardi, Marie Maulini, Federica Giannotti, Anne-Claire Mamez, Stavroula Masouridi-Levrat, Yves Chalandon, Dionysios Neofytos
Publikováno v:
Antimicrobial Agents and Chemotherapy. 67
We present two allogeneic hematopoietic cell transplantation recipients (HCTr) treated with pritelivir for acyclovir-resistant/refractory (r/r) HSV infection based on the expanded access program of the pritelivir manufacturer. Outpatient treatment wi
Autor:
Anne-Claire Mamez, Amandine Pradier, Caroline Stephan, Federica Giannotti, Stavroula Masouridi-Levrat, Sarah Morin, Dionysios Neofytos, Diem-Lan Vu, Astrid Melotti, Isabelle Arm-Vernez, Christiane S. Eberhardt, Jerome Tamburini, Laurent Kaiser, Yves Chalandon, Federico Simonetta
Publikováno v:
Blood. 140:10509-10511